Reference Database Development for the Quotient® System iPad Test

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD

Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant

PRC-063 Adult Laboratory Classroom Study in Adults With ADHD

A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD

A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD